TY - JOUR
T1 - Machine-Learning-Based In-Hospital Mortality Prediction for Transcatheter Mitral Valve Repair in the United States
AU - Hernandez-Suarez, Dagmar F.
AU - Ranka, Sagar
AU - Kim, Yeunjung
AU - Latib, Azeem
AU - Wiley, Jose
AU - Lopez-Candales, Angel
AU - Pinto, Duane S.
AU - Gonzalez, Maday C.
AU - Ramakrishna, Harish
AU - Sanina, Cristina
AU - Nieves-Rodriguez, Brenda G.
AU - Rodriguez-Maldonado, Jovaniel
AU - Feliu Maldonado, Roberto
AU - Rodriguez-Ruiz, Israel J.
AU - da Luz Sant'Ana, Istoni
AU - Wiley, Karlo A.
AU - Cox-Alomar, Pedro
AU - Villablanca, Pedro A.
AU - Roche-Lima, Abiel
N1 - Funding Information:
This study was funded by the National Institutes of Health (NIH), award numbers U54MD007587 , U54MD007600 , S21MD001830 , R25MD007607 , and TL1TR001434-3 . Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2021/1
Y1 - 2021/1
N2 - Background: Transcatheter mitral valve repair (TMVR) utilization has increased significantly in the United States over the last years. Yet, a risk-prediction tool for adverse events has not been developed. We aimed to generate a machine-learning-based algorithm to predict in-hospital mortality after TMVR. Methods: Patients who underwent TMVR from 2012 through 2015 were identified using the National Inpatient Sample database. The study population was randomly divided into a training set (n = 636) and a testing set (n = 213). Prediction models for in-hospital mortality were obtained using five supervised machine-learning classifiers. Results: A total of 849 TMVRs were analyzed in our study. The overall in-hospital mortality was 3.1%. A naïve Bayes (NB) model had the best discrimination for fifteen variables, with an area under the receiver-operating curve (AUC) of 0.83 (95% CI, 0.80–0.87), compared to 0.77 for logistic regression (95% CI, 0.58–0.95), 0.73 for an artificial neural network (95% CI, 0.55–0.91), and 0.67 for both a random forest and a support-vector machine (95% CI, 0.47–0.87). History of coronary artery disease, of chronic kidney disease, and smoking were the three most significant predictors of in-hospital mortality. Conclusions: We developed a robust machine-learning-derived model to predict in-hospital mortality in patients undergoing TMVR. This model is promising for decision-making and deserves further clinical validation.
AB - Background: Transcatheter mitral valve repair (TMVR) utilization has increased significantly in the United States over the last years. Yet, a risk-prediction tool for adverse events has not been developed. We aimed to generate a machine-learning-based algorithm to predict in-hospital mortality after TMVR. Methods: Patients who underwent TMVR from 2012 through 2015 were identified using the National Inpatient Sample database. The study population was randomly divided into a training set (n = 636) and a testing set (n = 213). Prediction models for in-hospital mortality were obtained using five supervised machine-learning classifiers. Results: A total of 849 TMVRs were analyzed in our study. The overall in-hospital mortality was 3.1%. A naïve Bayes (NB) model had the best discrimination for fifteen variables, with an area under the receiver-operating curve (AUC) of 0.83 (95% CI, 0.80–0.87), compared to 0.77 for logistic regression (95% CI, 0.58–0.95), 0.73 for an artificial neural network (95% CI, 0.55–0.91), and 0.67 for both a random forest and a support-vector machine (95% CI, 0.47–0.87). History of coronary artery disease, of chronic kidney disease, and smoking were the three most significant predictors of in-hospital mortality. Conclusions: We developed a robust machine-learning-derived model to predict in-hospital mortality in patients undergoing TMVR. This model is promising for decision-making and deserves further clinical validation.
KW - Machine learning
KW - Mortality
KW - Transcatheter mitral valve repair
UR - http://www.scopus.com/inward/record.url?scp=85086835019&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086835019&partnerID=8YFLogxK
U2 - 10.1016/j.carrev.2020.06.017
DO - 10.1016/j.carrev.2020.06.017
M3 - Article
C2 - 32591310
AN - SCOPUS:85086835019
SN - 1553-8389
VL - 22
SP - 22
EP - 28
JO - Cardiovascular Revascularization Medicine
JF - Cardiovascular Revascularization Medicine
ER -